Industry Research Reports

Home > Reports > Consumer Goods > Dog Pharmaceuticals and Supplements - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032

Dog Pharmaceuticals and Supplements - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032

Industry: Consumer Goods

Published Date: 2026-02-11

Pages: 122 Pages

Report ld: 5975320

Request Sample

Customized Report

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

The global market for Dog Pharmaceuticals and Supplements was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.

Veterinary pet supplements and nutraceuticals are widely used by dog, cat and horse owners across the United States, generating millions of dollars in revenue for manufacturers. Despite the widespread use of these veterinary products, oversight and regulation remain limited as compared to human dietary supplement regulations. This review describes the current regulation, quality control, safety and efficacy of pet supplements and nutraceuticals targeted towards the dog, cat and horse.

The North American market for Dog Pharmaceuticals and Supplements was valued at US$ million in 2025 and is projected to reach US$ million by 2032, at a CAGR of % from 2026 to 2032.

The Asia-Pacific market for Dog Pharmaceuticals and Supplements was valued at $ million in 2025 and is projected to climb to US$ million by 2032, at a CAGR of % from 2026 to 2032.

The European market for Dog Pharmaceuticals and Supplements was valued at $ million in 2025 and is projected to total US$ million by 2032, at a CAGR of % from 2026 to 2032.

The global key companies in the Dog Pharmaceuticals and Supplements market include Virbac, Zoetis, Vetoquinol, Nestle Purina, NOW Foods, Nutramax Laboratories, Bayer, Foodscience corporation, Manna Pro Products, Ark Naturals, etc. In 2025, the five largest players accounted for approximately % of revenue.

This report provides a comprehensive view of the global market for Dog Pharmaceuticals and Supplements, covering total sales revenue, the market share and ranking of key companies, along with analyses by region & country, by Type, and by Application.

The Dog Pharmaceuticals and Supplements market size, estimations, and forecasts are presented in terms of sales revenue ($ millions), with 2025 as the base year and historical and forecast data from 2021 to 2032. The report combines quantitative and qualitative analysis to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current marketplace, and make informed business decisions regarding Dog Pharmaceuticals and Supplements.

MARKET SEGMENTATION

By Company

Virbac
Zoetis
Vetoquinol
Nestle Purina
NOW Foods
Nutramax Laboratories
Bayer
Foodscience corporation
Manna Pro Products
Ark Naturals
Blackmores
Zesty Paws
Nuvetlabs
Mavlab
Vetafarm
Nupro Supplements

Consumption by Region

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
Latin America
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA

Segment by Type

Pharmaceuticals
Supplements

Segment by Application

Puppy
Adult Dogs

biaoTi CHAPTER OUTLINE

Chapter 1: Introduces the scope of the report and the global market size (value). It also summarizes market dynamics and recent developments; identifies key drivers and restraints; outlines challenges and risks for players; reviews relevant industry policies.

Chapter 2: Provides a detailed analysis of the Dog Pharmaceuticals and Supplements companies' competitive landscape—including revenue shares, recent development plans, and mergers and acquisitions (M&A).

Chapter 3: Analyzes market segmentation by Type, presenting the size and growth potential of each segment to help readers identify blue-ocean opportunities.

Chapter 4: Analyzes market segmentation by Application, presenting the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.

Chapter 5: Presents Dog Pharmaceuticals and Supplements revenue at the regional level. It offers a quantitative assessment of market size and growth potential by region and summarizes market development, future prospects, addressable space, and country-level market size worldwide.

Chapter 6: Presents Dog Pharmaceuticals and Supplements revenue at the country level. It provides segmented data by Type and by Application for each country/region.

Chapter 7: Profiles key players, detailing the main companies' product revenue, gross margin, product portfolios, recent developments, etc.

Chapter 8: Analysis of Value Chain, including the upstream and downstream of the industry.

Chapter 9: Conclusion.

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

TABLE OF CONTENTS

1 Market Overview

1.1 Dog Pharmaceuticals and Supplements Product Introduction

1.2 Global Dog Pharmaceuticals and Supplements Market Size Forecast (2021–2032)

1.3 Dog Pharmaceuticals and Supplements Market Trends & Drivers

1.3.1 Dog Pharmaceuticals and Supplements Industry Trends

1.3.2 Dog Pharmaceuticals and Supplements Market Drivers & Opportunities

1.3.3 Dog Pharmaceuticals and Supplements Market Challenges

1.3.4 Dog Pharmaceuticals and Supplements Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Dog Pharmaceuticals and Supplements Players Revenue Ranking (2025)

2.2 Global Dog Pharmaceuticals and Supplements Revenue by Company (2021–2026)

2.3 Key Companies’ R&D and Operations Footprint and Headquarters

2.4 Key Companies Dog Pharmaceuticals and Supplements Product Offerings

2.5 Key Companies General Availability (GA) Timeline for Dog Pharmaceuticals and Supplements

2.6 Dog Pharmaceuticals and Supplements Market Competitive Analysis

2.6.1 Dog Pharmaceuticals and Supplements Market Concentration Rate (2021–2026)

2.6.2 Top 5 and Top 10 Global Companies by Dog Pharmaceuticals and Supplements Revenue in 2025

2.6.3 Global Companies by Tier (Tier 1, Tier 2, Tier 3), based on Dog Pharmaceuticals and Supplements revenue, 2025

2.7 Mergers & Acquisitions and Expansion

3 Segmentation Dog Pharmaceuticals and Supplements Market Classification

3.1 Introduction by Type

3.1.1 Pharmaceuticals

3.1.2 Supplements

3.1.3 Global Dog Pharmaceuticals and Supplements Sales Value by Type

3.1.3.1 Global Dog Pharmaceuticals and Supplements Sales Value by Type (2021 vs 2025 vs 2032)

3.1.3.2 Global Dog Pharmaceuticals and Supplements Sales Value, by Type (2021–2032)

3.1.3.3 Global Dog Pharmaceuticals and Supplements Sales Value, by Type (%), 2021–2032

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Puppy

4.1.2 Adult Dogs

4.2 Global Dog Pharmaceuticals and Supplements Sales Value by Application

4.2.1 Global Dog Pharmaceuticals and Supplements Sales Value by Application (2021 vs 2025 vs 2032)

4.2.2 Global Dog Pharmaceuticals and Supplements Sales Value by Application (2021–2032)

4.2.3 Global Dog Pharmaceuticals and Supplements Sales Value by Application (%), 2021–2032

5 Segmentation by Region

5.1 Global Dog Pharmaceuticals and Supplements Sales Value by Region

5.1.1 Global Dog Pharmaceuticals and Supplements Sales Value by Region: 2021 vs 2025 vs 2032

5.1.2 Global Dog Pharmaceuticals and Supplements Sales Value by Region (2021–2026)

5.1.3 Global Dog Pharmaceuticals and Supplements Sales Value by Region (2027–2032)

5.1.4 Global Dog Pharmaceuticals and Supplements Sales Value by Region (%), 2021–2032

5.2 North America

5.2.1 North America Dog Pharmaceuticals and Supplements Sales Value, 2021–2032

5.2.2 North America Dog Pharmaceuticals and Supplements Sales Value by Country (%), 2025 vs 2032

5.3 Europe

5.3.1 Europe Dog Pharmaceuticals and Supplements Sales Value, 2021–2032

5.3.2 Europe Dog Pharmaceuticals and Supplements Sales Value by Country (%), 2025 vs 2032

5.4 Asia Pacific

5.4.1 Asia Pacific Dog Pharmaceuticals and Supplements Sales Value, 2021–2032

5.4.2 Asia Pacific Dog Pharmaceuticals and Supplements Sales Value by Subregion (%), 2025 vs 2032

5.5 South America

5.5.1 South America Dog Pharmaceuticals and Supplements Sales Value, 2021–2032

5.5.2 South America Dog Pharmaceuticals and Supplements Sales Value by Country (%), 2025 vs 2032

5.6 Middle East & Africa

5.6.1 Middle East & Africa Dog Pharmaceuticals and Supplements Sales Value, 2021–2032

5.6.2 Middle East & Africa Dog Pharmaceuticals and Supplements Sales Value by Country (%), 2025 vs 2032

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Dog Pharmaceuticals and Supplements Sales Value Growth Trends, 2021 vs 2025 vs 2032

6.2 Key Countries/Regions Dog Pharmaceuticals and Supplements Sales Value, 2021–2032

6.3 United States

6.3.1 United States Dog Pharmaceuticals and Supplements Sales Value, 2021–2032

6.3.2 United States Dog Pharmaceuticals and Supplements Sales Value by Type (%), 2025 vs 2032

6.3.3 United States Dog Pharmaceuticals and Supplements Sales Value by Application, 2025 vs 2032

6.4 Europe

6.4.1 Europe Dog Pharmaceuticals and Supplements Sales Value, 2021–2032

6.4.2 Europe Dog Pharmaceuticals and Supplements Sales Value by Type (%), 2025 vs 2032

6.4.3 Europe Dog Pharmaceuticals and Supplements Sales Value by Application, 2025 vs 2032

6.5 China

6.5.1 China Dog Pharmaceuticals and Supplements Sales Value, 2021–2032

6.5.2 China Dog Pharmaceuticals and Supplements Sales Value by Type (%), 2025 vs 2032

6.5.3 China Dog Pharmaceuticals and Supplements Sales Value by Application, 2025 vs 2032

6.6 Japan

6.6.1 Japan Dog Pharmaceuticals and Supplements Sales Value, 2021–2032

6.6.2 Japan Dog Pharmaceuticals and Supplements Sales Value by Type (%), 2025 vs 2032

6.6.3 Japan Dog Pharmaceuticals and Supplements Sales Value by Application, 2025 vs 2032

6.7 South Korea

6.7.1 South Korea Dog Pharmaceuticals and Supplements Sales Value, 2021–2032

6.7.2 South Korea Dog Pharmaceuticals and Supplements Sales Value by Type (%), 2025 vs 2032

6.7.3 South Korea Dog Pharmaceuticals and Supplements Sales Value by Application, 2025 vs 2032

6.8 Southeast Asia

6.8.1 Southeast Asia Dog Pharmaceuticals and Supplements Sales Value, 2021–2032

6.8.2 Southeast Asia Dog Pharmaceuticals and Supplements Sales Value by Type (%), 2025 vs 2032

6.8.3 Southeast Asia Dog Pharmaceuticals and Supplements Sales Value by Application, 2025 vs 2032

6.9 India

6.9.1 India Dog Pharmaceuticals and Supplements Sales Value, 2021–2032

6.9.2 India Dog Pharmaceuticals and Supplements Sales Value by Type (%), 2025 vs 2032

6.9.3 India Dog Pharmaceuticals and Supplements Sales Value by Application, 2025 vs 2032

7 Company Profiles

7.1 Virbac

7.1.1 Virbac Profile

7.1.2 Virbac Main Business

7.1.3 Virbac Dog Pharmaceuticals and Supplements Products, Services, and Solutions

7.1.4 Virbac Dog Pharmaceuticals and Supplements Revenue (US$ Million), 2021–2026

7.1.5 Virbac Recent Developments

7.2 Zoetis

7.2.1 Zoetis Profile

7.2.2 Zoetis Main Business

7.2.3 Zoetis Dog Pharmaceuticals and Supplements Products, Services, and Solutions

7.2.4 Zoetis Dog Pharmaceuticals and Supplements Revenue (US$ Million), 2021–2026

7.2.5 Zoetis Recent Developments

7.3 Vetoquinol

7.3.1 Vetoquinol Profile

7.3.2 Vetoquinol Main Business

7.3.3 Vetoquinol Dog Pharmaceuticals and Supplements Products, Services, and Solutions

7.3.4 Vetoquinol Dog Pharmaceuticals and Supplements Revenue (US$ Million), 2021–2026

7.3.5 Vetoquinol Recent Developments

7.4 Nestle Purina

7.4.1 Nestle Purina Profile

7.4.2 Nestle Purina Main Business

7.4.3 Nestle Purina Dog Pharmaceuticals and Supplements Products, Services, and Solutions

7.4.4 Nestle Purina Dog Pharmaceuticals and Supplements Revenue (US$ Million), 2021–2026

7.4.5 Nestle Purina Recent Developments

7.5 NOW Foods

7.5.1 NOW Foods Profile

7.5.2 NOW Foods Main Business

7.5.3 NOW Foods Dog Pharmaceuticals and Supplements Products, Services, and Solutions

7.5.4 NOW Foods Dog Pharmaceuticals and Supplements Revenue (US$ Million), 2021–2026

7.5.5 NOW Foods Recent Developments

7.6 Nutramax Laboratories

7.6.1 Nutramax Laboratories Profile

7.6.2 Nutramax Laboratories Main Business

7.6.3 Nutramax Laboratories Dog Pharmaceuticals and Supplements Products, Services, and Solutions

7.6.4 Nutramax Laboratories Dog Pharmaceuticals and Supplements Revenue (US$ Million), 2021–2026

7.6.5 Nutramax Laboratories Recent Developments

7.7 Bayer

7.7.1 Bayer Profile

7.7.2 Bayer Main Business

7.7.3 Bayer Dog Pharmaceuticals and Supplements Products, Services, and Solutions

7.7.4 Bayer Dog Pharmaceuticals and Supplements Revenue (US$ Million), 2021–2026

7.7.5 Bayer Recent Developments

7.8 Foodscience corporation

7.8.1 Foodscience corporation Profile

7.8.2 Foodscience corporation Main Business

7.8.3 Foodscience corporation Dog Pharmaceuticals and Supplements Products, Services, and Solutions

7.8.4 Foodscience corporation Dog Pharmaceuticals and Supplements Revenue (US$ Million), 2021–2026

7.8.5 Foodscience corporation Recent Developments

7.9 Manna Pro Products

7.9.1 Manna Pro Products Profile

7.9.2 Manna Pro Products Main Business

7.9.3 Manna Pro Products Dog Pharmaceuticals and Supplements Products, Services, and Solutions

7.9.4 Manna Pro Products Dog Pharmaceuticals and Supplements Revenue (US$ Million), 2021–2026

7.9.5 Manna Pro Products Recent Developments

7.10 Ark Naturals

7.10.1 Ark Naturals Profile

7.10.2 Ark Naturals Main Business

7.10.3 Ark Naturals Dog Pharmaceuticals and Supplements Products, Services, and Solutions

7.10.4 Ark Naturals Dog Pharmaceuticals and Supplements Revenue (US$ Million), 2021–2026

7.10.5 Ark Naturals Recent Developments

7.11 Blackmores

7.11.1 Blackmores Profile

7.11.2 Blackmores Main Business

7.11.3 Blackmores Dog Pharmaceuticals and Supplements Products, Services, and Solutions

7.11.4 Blackmores Dog Pharmaceuticals and Supplements Revenue (US$ Million), 2021–2026

7.11.5 Blackmores Recent Developments

7.12 Zesty Paws

7.12.1 Zesty Paws Profile

7.12.2 Zesty Paws Main Business

7.12.3 Zesty Paws Dog Pharmaceuticals and Supplements Products, Services, and Solutions

7.12.4 Zesty Paws Dog Pharmaceuticals and Supplements Revenue (US$ Million), 2021–2026

7.12.5 Zesty Paws Recent Developments

7.13 Nuvetlabs

7.13.1 Nuvetlabs Profile

7.13.2 Nuvetlabs Main Business

7.13.3 Nuvetlabs Dog Pharmaceuticals and Supplements Products, Services, and Solutions

7.13.4 Nuvetlabs Dog Pharmaceuticals and Supplements Revenue (US$ Million), 2021–2026

7.13.5 Nuvetlabs Recent Developments

7.14 Mavlab

7.14.1 Mavlab Profile

7.14.2 Mavlab Main Business

7.14.3 Mavlab Dog Pharmaceuticals and Supplements Products, Services, and Solutions

7.14.4 Mavlab Dog Pharmaceuticals and Supplements Revenue (US$ Million), 2021–2026

7.14.5 Mavlab Recent Developments

7.15 Vetafarm

7.15.1 Vetafarm Profile

7.15.2 Vetafarm Main Business

7.15.3 Vetafarm Dog Pharmaceuticals and Supplements Products, Services, and Solutions

7.15.4 Vetafarm Dog Pharmaceuticals and Supplements Revenue (US$ Million), 2021–2026

7.15.5 Vetafarm Recent Developments

7.16 Nupro Supplements

7.16.1 Nupro Supplements Profile

7.16.2 Nupro Supplements Main Business

7.16.3 Nupro Supplements Dog Pharmaceuticals and Supplements Products, Services, and Solutions

7.16.4 Nupro Supplements Dog Pharmaceuticals and Supplements Revenue (US$ Million), 2021–2026

7.16.5 Nupro Supplements Recent Developments

8 Industry Chain Analysis

8.1 Dog Pharmaceuticals and Supplements Value Chain

8.2 Dog Pharmaceuticals and Supplements Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Key Suppliers of Raw Materials

8.2.3 Cost Structure

8.3 Midstream Analysis

8.4 Downstream (Customer) Analysis

8.5 Sales Model and Sales Channelss

8.5.1 Dog Pharmaceuticals and Supplements Sales Model

8.5.2 Sales Channels

8.5.3 Dog Pharmaceuticals and Supplements Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.1.1 Research Programs/Design

10.1.1.2 Market Size Estimation

10.1.1.3 Market Breakdown and Data Triangulation

10.1.2 Data Source

10.1.2.1 Secondary Sources

10.1.2.2 Primary Sources

10.2 Author Details

10.3 Disclaimer

TABLE OF FIGURES

List of Tables

Table 1. Dog Pharmaceuticals and Supplements Market Trends

Table 2. Dog Pharmaceuticals and Supplements Market Drivers & Opportunities

Table 3. Dog Pharmaceuticals and Supplements Market Challenges

Table 4. Dog Pharmaceuticals and Supplements Market Restraints

Table 5. Global Dog Pharmaceuticals and Supplements Revenue by Company (US$ Million), 2021–2026

Table 6. Global Dog Pharmaceuticals and Supplements Revenue Market Share by Company (2021–2026)

Table 7. Key Companies’ R&D and Operations Footprint and Headquarters

Table 8. Key Companies Dog Pharmaceuticals and Supplements Product Type

Table 9. Key Companies General Availability (GA) Timeline for Dog Pharmaceuticals and Supplements

Table 10. Global Dog Pharmaceuticals and Supplements Companies Market Concentration Ratio (CR5 and HHI)

Table 11. Global Companies by Tier (Tier 1, Tier 2, Tier 3), based on Dog Pharmaceuticals and Supplements revenue, 2025

Table 12. Mergers & Acquisitions and Expansion Plans

Table 13. Global Dog Pharmaceuticals and Supplements Sales Value by Type: 2021 vs 2025 vs 2032 (US$ Million)

Table 14. Global Dog Pharmaceuticals and Supplements Sales Value by Type (US$ Million), 2021–2026

Table 15. Global Dog Pharmaceuticals and Supplements Sales Value by Type (US$ Million), 2027–2032

Table 16. Global Dog Pharmaceuticals and Supplements Sales Market Share in Value by Type (2021–2026)

Table 17. Global Dog Pharmaceuticals and Supplements Sales Market Share in Value by Type (2027–2032)

Table 18. Global Dog Pharmaceuticals and Supplements Sales Value by Application: 2021 vs 2025 vs 2032 (US$ Million)

Table 19. Global Dog Pharmaceuticals and Supplements Sales Value by Application (US$ Million), 2021–2026

Table 20. Global Dog Pharmaceuticals and Supplements Sales Value by Application (US$ Million), 2027–2032

Table 21. Global Dog Pharmaceuticals and Supplements Sales Market Share in Value by Application (2021–2026)

Table 22. Global Dog Pharmaceuticals and Supplements Sales Market Share in Value by Application (2027–2032)

Table 23. Global Dog Pharmaceuticals and Supplements Sales Value by Region, (US$ Million), 2021 vs 2025 vs 2032

Table 24. Global Dog Pharmaceuticals and Supplements Sales Value by Region (US$ Million), 2021–2026

Table 25. Global Dog Pharmaceuticals and Supplements Sales Value by Region (US$ Million), 2027–2032

Table 26. Global Dog Pharmaceuticals and Supplements Sales Value by Region (%), 2021–2026

Table 27. Global Dog Pharmaceuticals and Supplements Sales Value by Region (%), 2027–2032

Table 28. Key Countries/Regions Dog Pharmaceuticals and Supplements Sales Value Growth Trends, (US$ Million): 2021 vs 2025 vs 2032

Table 29. Key Countries/Regions Dog Pharmaceuticals and Supplements Sales Value, (US$ Million), 2021–2026

Table 30. Key Countries/Regions Dog Pharmaceuticals and Supplements Sales Value, (US$ Million), 2027–2032

Table 31. Virbac Basic Information List

Table 32. Virbac Description and Business Overview

Table 33. Virbac Dog Pharmaceuticals and Supplements Products, Services, and Solutions

Table 34. Revenue (US$ Million) in Dog Pharmaceuticals and Supplements Business of Virbac (2021–2026)

Table 35. Virbac Recent Developments

Table 36. Zoetis Basic Information List

Table 37. Zoetis Description and Business Overview

Table 38. Zoetis Dog Pharmaceuticals and Supplements Products, Services, and Solutions

Table 39. Revenue (US$ Million) in Dog Pharmaceuticals and Supplements Business of Zoetis (2021–2026)

Table 40. Zoetis Recent Developments

Table 41. Vetoquinol Basic Information List

Table 42. Vetoquinol Description and Business Overview

Table 43. Vetoquinol Dog Pharmaceuticals and Supplements Products, Services, and Solutions

Table 44. Revenue (US$ Million) in Dog Pharmaceuticals and Supplements Business of Vetoquinol (2021–2026)

Table 45. Vetoquinol Recent Developments

Table 46. Nestle Purina Basic Information List

Table 47. Nestle Purina Description and Business Overview

Table 48. Nestle Purina Dog Pharmaceuticals and Supplements Products, Services, and Solutions

Table 49. Revenue (US$ Million) in Dog Pharmaceuticals and Supplements Business of Nestle Purina (2021–2026)

Table 50. Nestle Purina Recent Developments

Table 51. NOW Foods Basic Information List

Table 52. NOW Foods Description and Business Overview

Table 53. NOW Foods Dog Pharmaceuticals and Supplements Products, Services, and Solutions

Table 54. Revenue (US$ Million) in Dog Pharmaceuticals and Supplements Business of NOW Foods (2021–2026)

Table 55. NOW Foods Recent Developments

Table 56. Nutramax Laboratories Basic Information List

Table 57. Nutramax Laboratories Description and Business Overview

Table 58. Nutramax Laboratories Dog Pharmaceuticals and Supplements Products, Services, and Solutions

Table 59. Revenue (US$ Million) in Dog Pharmaceuticals and Supplements Business of Nutramax Laboratories (2021–2026)

Table 60. Nutramax Laboratories Recent Developments

Table 61. Bayer Basic Information List

Table 62. Bayer Description and Business Overview

Table 63. Bayer Dog Pharmaceuticals and Supplements Products, Services, and Solutions

Table 64. Revenue (US$ Million) in Dog Pharmaceuticals and Supplements Business of Bayer (2021–2026)

Table 65. Bayer Recent Developments

Table 66. Foodscience corporation Basic Information List

Table 67. Foodscience corporation Description and Business Overview

Table 68. Foodscience corporation Dog Pharmaceuticals and Supplements Products, Services, and Solutions

Table 69. Revenue (US$ Million) in Dog Pharmaceuticals and Supplements Business of Foodscience corporation (2021–2026)

Table 70. Foodscience corporation Recent Developments

Table 71. Manna Pro Products Basic Information List

Table 72. Manna Pro Products Description and Business Overview

Table 73. Manna Pro Products Dog Pharmaceuticals and Supplements Products, Services, and Solutions

Table 74. Revenue (US$ Million) in Dog Pharmaceuticals and Supplements Business of Manna Pro Products (2021–2026)

Table 75. Manna Pro Products Recent Developments

Table 76. Ark Naturals Basic Information List

Table 77. Ark Naturals Description and Business Overview

Table 78. Ark Naturals Dog Pharmaceuticals and Supplements Products, Services, and Solutions

Table 79. Revenue (US$ Million) in Dog Pharmaceuticals and Supplements Business of Ark Naturals (2021–2026)

Table 80. Ark Naturals Recent Developments

Table 81. Blackmores Basic Information List

Table 82. Blackmores Description and Business Overview

Table 83. Blackmores Dog Pharmaceuticals and Supplements Products, Services, and Solutions

Table 84. Revenue (US$ Million) in Dog Pharmaceuticals and Supplements Business of Blackmores (2021–2026)

Table 85. Blackmores Recent Developments

Table 86. Zesty Paws Basic Information List

Table 87. Zesty Paws Description and Business Overview

Table 88. Zesty Paws Dog Pharmaceuticals and Supplements Products, Services, and Solutions

Table 89. Revenue (US$ Million) in Dog Pharmaceuticals and Supplements Business of Zesty Paws (2021–2026)

Table 90. Zesty Paws Recent Developments

Table 91. Nuvetlabs Basic Information List

Table 92. Nuvetlabs Description and Business Overview

Table 93. Nuvetlabs Dog Pharmaceuticals and Supplements Products, Services, and Solutions

Table 94. Revenue (US$ Million) in Dog Pharmaceuticals and Supplements Business of Nuvetlabs (2021–2026)

Table 95. Nuvetlabs Recent Developments

Table 96. Mavlab Basic Information List

Table 97. Mavlab Description and Business Overview

Table 98. Mavlab Dog Pharmaceuticals and Supplements Products, Services, and Solutions

Table 99. Revenue (US$ Million) in Dog Pharmaceuticals and Supplements Business of Mavlab (2021–2026)

Table 100. Mavlab Recent Developments

Table 101. Vetafarm Basic Information List

Table 102. Vetafarm Description and Business Overview

Table 103. Vetafarm Dog Pharmaceuticals and Supplements Products, Services, and Solutions

Table 104. Revenue (US$ Million) in Dog Pharmaceuticals and Supplements Business of Vetafarm (2021–2026)

Table 105. Vetafarm Recent Developments

Table 106. Nupro Supplements Basic Information List

Table 107. Nupro Supplements Description and Business Overview

Table 108. Nupro Supplements Dog Pharmaceuticals and Supplements Products, Services, and Solutions

Table 109. Revenue (US$ Million) in Dog Pharmaceuticals and Supplements Business of Nupro Supplements (2021–2026)

Table 110. Nupro Supplements Recent Developments

Table 111. Revenue (US$ Million) in Dog Pharmaceuticals and Supplements Business of Company 40 (2021–2026)

Table 112. Company 40 Recent Developments

Table 113. Key Raw Materials Lists

Table 114. Key Suppliers of Raw Materials Lists

Table 115. Dog Pharmaceuticals and Supplements Downstream Customers

Table 116. Dog Pharmaceuticals and Supplements Distributors List

Table 117. Research Programs/Design for This Report

Table 118. Key Data Information from Secondary Sources

Table 119. Key Data Information from Primary Sources

List of Figures

Figure 1. Dog Pharmaceuticals and Supplements Product Picture

Figure 2. Global Dog Pharmaceuticals and Supplements Sales Value, 2021 vs 2025 vs 2032 (US$ Million)

Figure 3. Global Dog Pharmaceuticals and Supplements Sales Value (US$ Million), 2021–2032

Figure 4. Dog Pharmaceuticals and Supplements Report Years Considered

Figure 5. Global Dog Pharmaceuticals and Supplements Players Revenue Ranking (US$ Million), 2025

Figure 6. The 5 and 10 Largest Companies in the World: Market Share by Dog Pharmaceuticals and Supplements Revenue in 2025

Figure 7. Dog Pharmaceuticals and Supplements Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025

Figure 8. Pharmaceuticals Picture

Figure 9. Supplements Picture

Figure 10. Global Dog Pharmaceuticals and Supplements Sales Value by Type (US$ Million), 2021 vs 2025 vs 2032

Figure 11. Global Dog Pharmaceuticals and Supplements Sales Value Market Share by Type, 2025 & 2032

Figure 12. Product Picture of Puppy

Figure 13. Product Picture of Adult Dogs

Figure 14. Global Dog Pharmaceuticals and Supplements Sales Value by Application (US$ Million), 2021 vs 2025 vs 2032

Figure 15. Global Dog Pharmaceuticals and Supplements Sales Value Market Share by Application, 2025 & 2032

Figure 16. North America Dog Pharmaceuticals and Supplements Sales Value (US$ Million), 2021–2032

Figure 17. North America Dog Pharmaceuticals and Supplements Sales Value by Country (%), 2025 vs 2032

Figure 18. Europe Dog Pharmaceuticals and Supplements Sales Value (US$ Million), 2021–2032

Figure 19. Europe Dog Pharmaceuticals and Supplements Sales Value by Country (%), 2025 vs 2032

Figure 20. Asia Pacific Dog Pharmaceuticals and Supplements Sales Value (US$ Million), 2021–2032

Figure 21. Asia Pacific Dog Pharmaceuticals and Supplements Sales Value by Subregion (%), 2025 vs 2032

Figure 22. South America Dog Pharmaceuticals and Supplements Sales Value (US$ Million), 2021–2032

Figure 23. South America Dog Pharmaceuticals and Supplements Sales Value by Country (%), 2025 vs 2032

Figure 24. Middle East & Africa Dog Pharmaceuticals and Supplements Sales Value (US$ Million), 2021–2032

Figure 25. Middle East & Africa Dog Pharmaceuticals and Supplements Sales Value by Country (%), 2025 vs 2032

Figure 26. Key Countries/Regions Dog Pharmaceuticals and Supplements Sales Value (%), 2021–2032

Figure 27. United States Dog Pharmaceuticals and Supplements Sales Value (US$ Million), 2021–2032

Figure 28. United States Dog Pharmaceuticals and Supplements Sales Value by Type (%), 2025 vs 2032

Figure 29. United States Dog Pharmaceuticals and Supplements Sales Value by Application (%), 2025 vs 2032

Figure 30. Europe Dog Pharmaceuticals and Supplements Sales Value (US$ Million), 2021–2032

Figure 31. Europe Dog Pharmaceuticals and Supplements Sales Value by Type (%), 2025 vs 2032

Figure 32. Europe Dog Pharmaceuticals and Supplements Sales Value by Application (%), 2025 vs 2032

Figure 33. China Dog Pharmaceuticals and Supplements Sales Value (US$ Million), 2021–2032

Figure 34. China Dog Pharmaceuticals and Supplements Sales Value by Type (%), 2025 vs 2032

Figure 35. China Dog Pharmaceuticals and Supplements Sales Value by Application (%), 2025 vs 2032

Figure 36. Japan Dog Pharmaceuticals and Supplements Sales Value (US$ Million), 2021–2032

Figure 37. Japan Dog Pharmaceuticals and Supplements Sales Value by Type (%), 2025 vs 2032

Figure 38. Japan Dog Pharmaceuticals and Supplements Sales Value by Application (%), 2025 vs 2032

Figure 39. South Korea Dog Pharmaceuticals and Supplements Sales Value (US$ Million), 2021–2032

Figure 40. South Korea Dog Pharmaceuticals and Supplements Sales Value by Type (%), 2025 vs 2032

Figure 41. South Korea Dog Pharmaceuticals and Supplements Sales Value by Application (%), 2025 vs 2032

Figure 42. Southeast Asia Dog Pharmaceuticals and Supplements Sales Value (US$ Million), 2021–2032

Figure 43. Southeast Asia Dog Pharmaceuticals and Supplements Sales Value by Type (%), 2025 vs 2032

Figure 44. Southeast Asia Dog Pharmaceuticals and Supplements Sales Value by Application (%), 2025 vs 2032

Figure 45. India Dog Pharmaceuticals and Supplements Sales Value (US$ Million), 2021–2032

Figure 46. India Dog Pharmaceuticals and Supplements Sales Value by Type (%), 2025 vs 2032

Figure 47. India Dog Pharmaceuticals and Supplements Sales Value by Application (%), 2025 vs 2032

Figure 48. Dog Pharmaceuticals and Supplements Value Chain

Figure 49. Dog Pharmaceuticals and Supplements Cost Structure

Figure 50. Channels of Distribution (Direct Sales, and Distribution)

Figure 51. Bottom-up and Top-down Approaches for This Report

Figure 52. Data Triangulation

Figure 53. Key Executives Interviewed

KEY QUESTIONS ADDRESSED BY THE REPORT

Which companies rank high in the global Dog Pharmaceuticals and Supplements market? zhanKai

The top companies in the global Dog Pharmaceuticals and Supplements market are Virbac、Zoetis、Vetoquinol.

Related Reports

Global Dog Pharmaceuticals and Supplements Market Research Report 2026
The global Dog Pharmaceuticals and Supplements market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-02-11
Pages: 129
USD 2900.00
(Single User License)
Global Dog Pharmaceuticals and Supplements Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Dog Pharmaceuticals and Supplements market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.
Published Date: 2025-10-03
Pages: 158
USD 4900.00
(Single User License)
Global Dog Pharmaceuticals and Supplements Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Dog Pharmaceuticals and Supplements market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-09-06
Pages: 104
USD 4250.00
(Single User License)
Dog Pharmaceuticals and Supplements- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Dog Pharmaceuticals and Supplements was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-03-02
Pages: 123
USD 3950.00
(Single User License)
Global Dog Pharmaceuticals and Supplements Market Research Report 2025
The global market for Dog Pharmaceuticals and Supplements was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-03-02
Pages: 97
USD 2900.00
(Single User License)
Global Dog Pharmaceuticals and Supplements Market Insights, Forecast to 2030
Veterinary pet supplements and nutraceuticals are widely used by dog, cat and horse owners across the United States, generating millions of dollars in revenue for manufacturers. Despite the widespread use of these veterinary products, oversight and regulation remain limited as compared to human dietary supplement regulations. This review describes the current regulation, quality control, safety and efficacy of pet supplements and nutraceuticals targeted towards the dog, cat and horse.
Published Date: 2024-04-26
Pages: 112
USD 4900.00
(Single User License)

Global Dog Pharmaceuticals and Supplements Market Research Report 2026
The global Dog Pharmaceuticals and Supplements market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-02-11
Pages: 129
USD 2900.00 (Single User License)
Global Dog Pharmaceuticals and Supplements Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Dog Pharmaceuticals and Supplements market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.
Published: 2025-10-03
Pages: 158
USD 4900.00 (Single User License)
Global Dog Pharmaceuticals and Supplements Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Dog Pharmaceuticals and Supplements market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-09-06
Pages: 104
USD 4250.00 (Single User License)
Dog Pharmaceuticals and Supplements- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Dog Pharmaceuticals and Supplements was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-03-02
Pages: 123
USD 3950.00 (Single User License)
Global Dog Pharmaceuticals and Supplements Market Research Report 2025
The global market for Dog Pharmaceuticals and Supplements was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-03-02
Pages: 97
USD 2900.00 (Single User License)
Global Dog Pharmaceuticals and Supplements Market Insights, Forecast to 2030
Veterinary pet supplements and nutraceuticals are widely used by dog, cat and horse owners across the United States, generating millions of dollars in revenue for manufacturers. Despite the widespread use of these veterinary products, oversight and regulation remain limited as compared to human dietary supplement regulations. This review describes the current regulation, quality control, safety and efficacy of pet supplements and nutraceuticals targeted towards the dog, cat and horse.
Published: 2024-04-26
Pages: 112
USD 4900.00 (Single User License)